U.S. Paper and Forestry Products Stock News

NYSE:OVV
NYSE:OVVOil and Gas

Should Ovintiv’s (OVV) Cash Generation Amid Q1 Losses Require Action From Investors?

Ovintiv Inc. has already reported first-quarter 2026 results, with revenue rising to US$2,532 million while a US$630 million net loss reflected large non-cash impairments alongside active portfolio reshaping and a US$0.30 per-share dividend declaration. Amid higher production volumes, reaffirmed 2026 guidance, and resumed share buybacks, Ovintiv paired a wider accounting loss with strong cash generation and an ongoing commitment to returning free cash flow to shareholders. We will now...
NasdaqGS:ATEC
NasdaqGS:ATECMedical Equipment

Insider Buying And New Credit Facility Reshape Alphatec Holdings Risk Profile

In May 2026, Alphatec Holdings director Keith Valentine made substantial insider purchases of NasdaqGS:ATEC shares. At the same time, Alphatec refinanced its debt with a new syndicated bank credit facility. The facility adjusts the company’s interest costs and extends debt maturities, while simplifying its capital structure. Alphatec Holdings, listed on NasdaqGS:ATEC, focuses on spine surgery solutions, a segment that often attracts attention as populations age and demand for orthopedic and...
NYSE:Q
NYSE:QSemiconductor

Qnity Electronics (Q) Is Up 8.4% After Raising 2026 AI‑Driven Guidance – Has The Bull Case Changed?

In May 2026, Qnity Electronics reported first‑quarter 2026 results showing net sales rising to US$1.315 billion while GAAP net income and earnings per share fell year over year, but adjusted earnings and margins improved. The company also raised its full‑year 2026 guidance for sales and adjusted earnings, highlighting strong demand from AI and high‑performance computing customers, reinforced by new collaborations with Nvidia and participation in Apple’s American Manufacturing program. Next,...
NYSE:BILL
NYSE:BILLSoftware

BILL Holdings Faces Activist Pressure As Buybacks And M&A Interest Grow

Activist investors, including Elliott Investment Management and Starboard Value, are reported to have built significant stakes in BILL Holdings (NYSE:BILL). These investors are pushing for a potential sale of the company, with BILL Holdings said to be reviewing strategic alternatives. Private equity firms and software focused buyers are reportedly showing fresh interest in acquiring the company following its valuation reset. BILL Holdings, which last closed at $39.96, is back in focus as...
NasdaqGS:EXLS
NasdaqGS:EXLSProfessional Services

ExlService Names Singh To Lead EMEA And APAC As Shares Lag Targets

ExlService Holdings (NasdaqGS:EXLS) has appointed Bhupender Singh as President and Head of International Growth Markets. Singh will lead expansion across EMEA and APAC, focusing on data and AI-driven services. The move targets growth outside EXL's core US business and reflects an increased focus on international opportunities. For investors tracking NasdaqGS:EXLS, this leadership change comes after a tough share price period. The stock closed at $27.16, with the share price down 12.3% over...
NasdaqGM:MAZE
NasdaqGM:MAZEPharmaceuticals

Maze Therapeutics (MAZE) Q1 Loss Of US$24.2 Million Reinforces Bearish Earnings Narratives

Maze Therapeutics (MAZE) opened Q1 2026 with revenue of US$20 million and a basic EPS loss of US$0.45, alongside a net income loss of US$24.21 million, setting an earnings-season tone that is still firmly focused on managing losses. Over the past few quarters the company has gone from zero reported revenue in each quarter of 2025 to US$20 million in Q1 2026. Quarterly basic EPS has ranged from a loss of US$1.15 in Q1 2025 to a loss of US$0.45 in the latest period, putting the spotlight on how...
NasdaqCM:IRD
NasdaqCM:IRDBiotechs

Opus Genetics (IRD) Q1 Loss Of US$65.5 Million Intensifies Bearish Community Narratives

Opus Genetics (IRD) opened Q1 2026 with revenue of US$2.2 million and a basic EPS loss of US$0.75, putting a clear focus on how much cash the business is burning to support its growth plans. The company has reported quarterly revenue between US$2.9 million and US$4.4 million over the past five periods, while basic EPS losses have ranged from US$0.12 to US$1.16, giving investors a broad view of how the income statement changes as spending shifts. With profitability still some way off and...
NYSE:REZI
NYSE:REZIBuilding

Resideo Sets Leadership For ADI Spin Off As Valuation Draws Attention

Resideo Technologies (NYSE:REZI) announced new leadership appointments for both Resideo and its planned spin off, ADI Global Distribution. The company outlined executive and board roles that will govern each business after the separation is complete. The spin off of ADI Global Distribution remains on track for completion between the third and fourth quarters of 2026. Resideo, which focuses on comfort, security and related products and services for homes and businesses, is preparing to...
NYSE:NEE
NYSE:NEEElectric Utilities

Record Q1 Profits And Renewables Backlog Surge Could Be A Game Changer For NextEra Energy (NEE)

In early May 2026, NextEra Energy reported a very large year-on-year profit increase in its Q1 results and a record quarter for its renewables and storage unit, which added 4 GW of projects to its backlog and drew positive attention from multiple Wall Street research firms. This combination of strong quarterly performance and a growing pipeline in renewables and storage underscores how central NextEra has become to supplying power for data centers and the broader shift toward...
NasdaqGS:NCMI
NasdaqGS:NCMIMedia

National CineMedia (NCMI) Q1 Loss Reopens Debate Around Earnings Stability Narratives

Q1 2026 earnings snapshot National CineMedia (NCMI) has reported Q1 2026 revenue of US$34 million with a basic EPS loss of US$0.31, while trailing twelve month figures show revenue of US$242.3 million and a basic EPS loss of US$0.09. Over recent quarters, the company has seen quarterly revenue range from US$34 million to US$93.2 million, with basic EPS moving between a loss of US$0.32 and a profit of US$0.31. This sets up a mixed picture on earnings quality and operating leverage. For...
NasdaqGS:LEGN
NasdaqGS:LEGNBiotechs

Legend Biotech (LEGN) Q1 Loss Persists And Tests Bullish Profitability Narratives

Legend Biotech (LEGN) has reported Q1 2026 revenue of US$305.1 million, with a basic EPS loss of US$0.29 and a net loss of US$54.3 million, setting the tone for a quarter where top line scale contrasts with continued spending. Over recent periods, revenue has moved from US$186.6 million in Q4 2024 to US$195.1 million in Q1 2025 and then to US$305.1 million in Q1 2026. Basic EPS has shifted from a profit of US$0.14 in Q4 2024 to losses of US$0.55 in Q1 2025 and US$0.29 in Q1 2026, leaving...
NYSE:INR
NYSE:INROil and Gas

Infinity Natural Resources (INR) Quarterly Loss Revives Concerns Over Earnings Quality Narratives

Infinity Natural Resources (INR) opened 2026 with Q1 revenue of US$154.9 million, a reported loss of US$1.9 million and basic EPS of US$0.11 loss, setting a mixed backdrop for investors reviewing the latest quarter. Over the past few reported periods the company has seen revenue move from US$69.1 million in Q4 2024 to US$85.2 million in Q1 2025, US$74.5 million in Q2 2025, US$79.7 million in Q3 2025 and US$117.1 million in Q4 2025, alongside EPS that has swung between a loss of US$2.27 and a...
NYSE:BEN
NYSE:BENCapital Markets

Franklin Resources Explores Onchain And Private Markets As Shares Outpace Targets

Franklin Resources (NYSE:BEN), through Franklin Templeton, has entered an onchain collaboration with Payward, the operator of Kraken, to develop tokenized, actively managed investments for institutional clients. The company has also launched Private Markets Model Portfolios with Corastone, aiming to give financial advisors more efficient access to diversified private market investments. These product moves come as Franklin Resources trades around $32.04, with the stock up 2.8% over the past...
NasdaqGS:TSEM
NasdaqGS:TSEMSemiconductor

Tower Semiconductor AI Photonics Deals Contrast With Rich Valuation Metrics

Tower Semiconductor (NasdaqGS:TSEM) secured US$1.3b in long-term silicon photonics contracts for 2027 with major customers. The agreements include substantial capacity-reservation prepayments tied to future production. Contract scope supports Tower's planned expansion in AI and data center related optical connectivity. These commitments arrive as the company prepares for a larger manufacturing footprint. Tower Semiconductor focuses on analog and specialty foundry manufacturing, and silicon...
NasdaqGM:TLSI
NasdaqGM:TLSIBiotechs

TriSalus Life Sciences (TLSI) Turns Q1 2026 Profit Challenging Persistent Loss Narratives

TriSalus Life Sciences (TLSI) opened 2026 with Q1 revenue of US$8.9 million and basic EPS of US$0.03, a sharp contrast to the loss of US$0.39 per share on US$9.2 million of revenue in Q1 2025. Over the last year, the company has seen revenue move from US$29.4 million on a trailing basis in Q4 2024 to US$44.9 million in Q1 2026, while trailing EPS remained at a loss of US$1.31 per share, keeping the spotlight firmly on how efficiently that top line is being converted into earnings. Margins are...
NYSE:SNX
NYSE:SNXElectronic

TD SYNNEX Expands Cybersecurity Story With Aura Identity BYOD Partnership

TD SYNNEX (NYSE:SNX) has partnered with Aura Business to distribute identity-centric BYOD security solutions across its reseller and MSP network. The collaboration focuses on securing remote and hybrid work setups while maintaining end user privacy. The Aura Business platform will be offered to TD SYNNEX partners as part of its broader cybersecurity and endpoint protection portfolio. For investors tracking TD SYNNEX at a share price of $231.75, this agreement comes during a period of strong...
NYSE:IFF
NYSE:IFFChemicals

IFF Vanilla Hub In Madagascar Ties Origin Sourcing To Undervalued Stock Narrative

IFF (NYSE:IFF) has opened a Vanilla Innovation Center in Madagascar, a key origin for natural vanilla. The facility is intended to focus on origin-based product development, sustainability, and local supply chain support. The center links Madagascar vanilla production with IFF’s broader global vanilla network for food, beverage, and fragrance customers. For investors watching NYSE:IFF, this move sits at the intersection of flavor, fragrance, and consumer demand for traceable, natural...
NasdaqCM:EVLV
NasdaqCM:EVLVElectronic

Evolv Technologies Holdings (EVLV) Q1 Loss Challenges Bullish Profitability Narratives

Evolv Technologies Holdings (EVLV) Q1 2026 earnings snapshot Evolv Technologies Holdings (EVLV) opened 2026 with Q1 revenue of US$46.3 million and a basic EPS loss of US$0.03, as investors weigh those figures against a share price of US$6.02. The company reported quarterly revenue of US$32.0 million in Q1 2025 and US$46.3 million in Q1 2026, while basic EPS moved from a loss of US$0.01 in Q1 2025 to a profit of US$0.06 in Q4 2025 before reverting to a loss this quarter. This keeps the...
NasdaqGS:SND
NasdaqGS:SNDEnergy Services

Smart Sand (SND) Swings To Q1 Loss Challenging Trailing Profitability Narrative

Smart Sand (SND) opened 2026 with Q1 revenue of US$93.1 million and a reported loss per share of US$0.10, as net income excluding extra items came in at a loss of US$3.9 million. Over the past year, the company has seen quarterly revenue move between US$65.6 million and US$93.1 million, while quarterly EPS has ranged from a loss of US$0.62 to a profit of US$0.55, with trailing twelve month EPS at US$0.56. For investors, the shift to positive earnings on a trailing basis, alongside a soft...
NasdaqGS:MRNA
NasdaqGS:MRNABiotechs

Moderna’s TIME Ranking And Combo Vaccine Approval Reshape Growth Question

Moderna (NasdaqGS:MRNA) ranked no. 1 on TIME's 2026 World's Most Impactful Companies list. The company received European approval for mCOMBRIAX, its first combined flu and COVID vaccine. These developments expand Moderna's recognized societal role and add a new approved product beyond COVID-only vaccines. For investors following Moderna, this recognition and new approval come as the company continues to build around its mRNA platform in vaccines and therapeutics. The flu plus COVID product...
NYSE:HHH
NYSE:HHHReal Estate

Has Howard Hughes Holdings (HHH) Fallen Too Far After Recent Share Price Weakness

Wondering whether Howard Hughes Holdings at around US$64.21 is priced for a rebound or still has more to prove on value? This article focuses squarely on what the current share price might imply. The stock has been fairly flat in the short term, up about 0.1% over the last week and down 0.2% over the last month, while the share price has declined 18.5% year to date and 9.6% over the last year. Those longer term moves sit against a backdrop of ongoing interest in real estate development and...
NasdaqGS:ATRO
NasdaqGS:ATROAerospace & Defense

Astronics (ATRO) Q1 EPS Surge Tests Bullish Earnings Growth Narrative

Astronics (ATRO) opened 2026 with Q1 revenue of US$230.6 million and basic EPS of US$1.38, setting a clear marker for how the year is starting after a busy 2025. The company has seen quarterly revenue move from US$205.9 million and EPS of US$0.27 in Q1 2025 to US$230.6 million and EPS of US$1.38 in Q1 2026, while trailing twelve month revenue sits at US$886.8 million and EPS at US$1.28. This puts the spotlight firmly on how much of this uplift is sticking in margins. See our full analysis for...
NasdaqCM:BWEN
NasdaqCM:BWENElectrical

Broadwind (BWEN) Q1 Loss And Earnings Volatility Test Bullish Profitability Narrative

Broadwind (BWEN) opened Q1 2026 with revenue of US$34.1 million and a basic EPS loss of US$0.02, compared with revenue of US$36.8 million and a basic EPS loss of US$0.02 in Q1 2025, while trailing twelve month EPS stood at US$0.22 on revenue of US$155.3 million. Over recent quarters the company has seen revenue move from US$33.6 million in Q4 2024 to US$36.8 million in Q1 2025, then to US$39.2 million in Q2 2025, US$44.2 million in Q3 2025, US$37.7 million in Q4 2025, and US$34.1 million in...
NYSE:AFL
NYSE:AFLInsurance

Aflac Cancer Initiative And New 10% Holder Shape Valuation Debate

Aflac (NYSE:AFL) is spotlighting its Check for Cancer Champion initiative, honoring television personality Adamari López for her cancer awareness advocacy. Separately, a regulatory filing disclosed that J&A Alliance Holdings, linked to Japan Post Holdings, holds a 10% stake in Aflac. Aflac, trading at $115.48, has a track record that includes a 13.6% return over the past year and 130.9% over the past 5 years. Those figures, alongside a 4.8% return year to date, suggest that many investors...